AIDS-related mycoses: the way forward

Trends Microbiol. 2014 Mar;22(3):107-9. doi: 10.1016/j.tim.2013.12.008.

Abstract

The contribution of fungal infections to the morbidity and mortality of HIV-infected individuals is largely unrecognized. A recent meeting highlighted several priorities that need to be urgently addressed, including improved epidemiological surveillance, increased availability of existing diagnostics and drugs, more training in the field of medical mycology, and better funding for research and provision of treatment, particularly in developing countries.

Keywords: AIDS; HIV; fungal infection; immunity; mortality; translational research.

Publication types

  • Congress

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / epidemiology*
  • AIDS-Related Opportunistic Infections / microbiology*
  • Acquired Immunodeficiency Syndrome / complications*
  • Antifungal Agents / therapeutic use
  • Humans
  • Mycoses / diagnosis
  • Mycoses / drug therapy*
  • Mycoses / epidemiology*

Substances

  • Antifungal Agents